Cargando…

The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle

BACKGROUND: Retinal toxicity is a rare adverse event related to the use of hydroxychloroquine (HCQ). To address this, in 2016, the American Academy of Ophthalmology (AAO) issued guidelines recommending that HCQ not exceed 5 mg/kg/day. We analyzed HCQ prescribing habits at our institution, compared t...

Descripción completa

Detalles Bibliográficos
Autores principales: Overbury, Rebecca S., Stoddard, Gregory J., Pupaibool, Jakrapun, Hansen, Christopher B., Lebiedz-Odrobina, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418105/
https://www.ncbi.nlm.nih.gov/pubmed/34479563
http://dx.doi.org/10.1186/s12913-021-06954-8
_version_ 1783748515253452800
author Overbury, Rebecca S.
Stoddard, Gregory J.
Pupaibool, Jakrapun
Hansen, Christopher B.
Lebiedz-Odrobina, Dorota
author_facet Overbury, Rebecca S.
Stoddard, Gregory J.
Pupaibool, Jakrapun
Hansen, Christopher B.
Lebiedz-Odrobina, Dorota
author_sort Overbury, Rebecca S.
collection PubMed
description BACKGROUND: Retinal toxicity is a rare adverse event related to the use of hydroxychloroquine (HCQ). To address this, in 2016, the American Academy of Ophthalmology (AAO) issued guidelines recommending that HCQ not exceed 5 mg/kg/day. We analyzed HCQ prescribing habits at our institution, compared to these guidelines, and used surveys to determine the opinions on these guidelines. We then introduced, in a prospective and non-controlled study, a clinical decision support (CDS) tool into the electronic medical record (EMR) to study how this intervention might affect adherence with or opinions on these guidelines. METHODS: Data were collected pre-intervention (June 2017–January 2019) and post-intervention (March 2019–April 2020). In January 2019 we released our CDS tool. Results were analyzed using descriptive statistics for demographic data and Fisher’s exact tests for comparisons of proportions between groups. RESULTS: Pre-intervention, we reviewed 1128 rheumatology charts and 282 dermatology charts. 31.0 and 39.7% respectively (32.8% combined) were prescribed HCQ > 5 .0 mg/kg/day. Post-intervention, we reviewed 1161 rheumatology charts and 110 dermatology charts. 23.0 and 25.5% respectively (23.2% combined) were prescribed HCQ > 5.0 mg/kg/day. Post-intervention, 9.6% fewer patients were prescribed HCQ > 5 mg/kg/day (P < .001). Pre-intervention, we compiled 18 rheumatology surveys and 12 dermatology surveys. Post-intervention, we compiled 16 rheumatology surveys and 12 dermatology surveys. Post-intervention, fewer rheumatologists incorrectly described the AAO weight-based guidelines. Combined, there was an overall reduction but not of statistical significance (P = .47). The majority of providers surveyed believed that the CDS tool was useful (72.2%). CONCLUSIONS: At our academic institution, there remains unfamiliarity with and hesitation to comply with the 2016 AAO guidelines. Prescribed doses often exceed what is recommended in these guidelines. A CDS tool can improve adherence with these guidelines and might improve providers’ familiarity with these guidelines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06954-8.
format Online
Article
Text
id pubmed-8418105
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84181052021-09-09 The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle Overbury, Rebecca S. Stoddard, Gregory J. Pupaibool, Jakrapun Hansen, Christopher B. Lebiedz-Odrobina, Dorota BMC Health Serv Res Research BACKGROUND: Retinal toxicity is a rare adverse event related to the use of hydroxychloroquine (HCQ). To address this, in 2016, the American Academy of Ophthalmology (AAO) issued guidelines recommending that HCQ not exceed 5 mg/kg/day. We analyzed HCQ prescribing habits at our institution, compared to these guidelines, and used surveys to determine the opinions on these guidelines. We then introduced, in a prospective and non-controlled study, a clinical decision support (CDS) tool into the electronic medical record (EMR) to study how this intervention might affect adherence with or opinions on these guidelines. METHODS: Data were collected pre-intervention (June 2017–January 2019) and post-intervention (March 2019–April 2020). In January 2019 we released our CDS tool. Results were analyzed using descriptive statistics for demographic data and Fisher’s exact tests for comparisons of proportions between groups. RESULTS: Pre-intervention, we reviewed 1128 rheumatology charts and 282 dermatology charts. 31.0 and 39.7% respectively (32.8% combined) were prescribed HCQ > 5 .0 mg/kg/day. Post-intervention, we reviewed 1161 rheumatology charts and 110 dermatology charts. 23.0 and 25.5% respectively (23.2% combined) were prescribed HCQ > 5.0 mg/kg/day. Post-intervention, 9.6% fewer patients were prescribed HCQ > 5 mg/kg/day (P < .001). Pre-intervention, we compiled 18 rheumatology surveys and 12 dermatology surveys. Post-intervention, we compiled 16 rheumatology surveys and 12 dermatology surveys. Post-intervention, fewer rheumatologists incorrectly described the AAO weight-based guidelines. Combined, there was an overall reduction but not of statistical significance (P = .47). The majority of providers surveyed believed that the CDS tool was useful (72.2%). CONCLUSIONS: At our academic institution, there remains unfamiliarity with and hesitation to comply with the 2016 AAO guidelines. Prescribed doses often exceed what is recommended in these guidelines. A CDS tool can improve adherence with these guidelines and might improve providers’ familiarity with these guidelines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06954-8. BioMed Central 2021-09-03 /pmc/articles/PMC8418105/ /pubmed/34479563 http://dx.doi.org/10.1186/s12913-021-06954-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Overbury, Rebecca S.
Stoddard, Gregory J.
Pupaibool, Jakrapun
Hansen, Christopher B.
Lebiedz-Odrobina, Dorota
The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title_full The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title_fullStr The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title_full_unstemmed The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title_short The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
title_sort effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 american academy of ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418105/
https://www.ncbi.nlm.nih.gov/pubmed/34479563
http://dx.doi.org/10.1186/s12913-021-06954-8
work_keys_str_mv AT overburyrebeccas theeffectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT stoddardgregoryj theeffectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT pupaibooljakrapun theeffectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT hansenchristopherb theeffectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT lebiedzodrobinadorota theeffectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT overburyrebeccas effectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT stoddardgregoryj effectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT pupaibooljakrapun effectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT hansenchristopherb effectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle
AT lebiedzodrobinadorota effectofanelectronicmedicalrecordinterventiononhydroxychloroquineprescribinghabitsandsurveyedprovidersopinionsofthe2016americanacademyofophthalmologyguidelinesintherheumatologyanddermatologypracticesofanacademicinstitutionle